Chemokine receptor 7 promotes cell migration and adhesion in metastatic squamous cell carcinoma of the head and neck by activating integrin αvβ3

International Journal of Molecular Medicine

Volumn 27, Issue 5, 2011, Pages 679-687

  Li, Peng ^a   Liu, Fayu ^a   Sun, Liyan ^a   Zhao, Zhenjin ^a   Ding, Xue ^a   Shang, Dehao ^a   Xu, Zhongfei ^a   Sun, Changfu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Adhesion; Chemokine receptor 7; Integrin v 3; Migration; Squamous cell carcinoma of the head and neck

Indexed keywords

ACTIN; CHEMOKINE RECEPTOR CCR7; IS 20; IS 201; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; CANCER SIZE; CANCER STAGING; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ACTINS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CCL19; CYTOSKELETON; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INTEGRIN ALPHAVBETA3; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PHOSPHORYLATION; RECEPTORS, CCR7;

EID: 79952940424     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.628     Document Type: Article

References (37)

1. Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572, 2002.
2. Yoon Y, Liang Z, Zhang X, Choe M, Zhu A, Cho HT, Shin DM, Goodman MM, Chen ZG and Shim H: CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models. Cancer Res 67: 7518-7524, 2007. (Pubitemid 47206582)
3. Younes MN, Yigitbasi OG, Yazici YD, Jasser SA, Bucana CD, EI-Naggar AK, Mills GB and Myers JN: Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 133: 15-23, 2007. (Pubitemid 46129500)
4. Yanagawa Y and Onoé K: CCL19 induces rapid dendritic extension of murine dendritic cells. Blood 100: 1948-1956, 2002.
5. Nagira M, Imai T, Yoshida R, Takagi S, Iwasaki M, Baba M, Tabira Y, Akagi J, Nomiyama H and Yoshie O: A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine (SLC), is a highly efficient chemoattractant for B cells and activated T cells. Eur J Immunol 28: 1516-1523, 1998. (Pubitemid 28221154)
6. Takanami I: Overexpression of CCR7 mRNA in non small cell lung cancer: correlation with lymph node metastasis. Int J Cancer 105: 186-189, 2003.
7. Zlotnik A: Chemokines and cancer. Int J Cancer 119: 2026-2029, 2006.
8. Arigami T, Natsugoe S, Uenosono Y, Yanagita S, Arima H, Hirata M, Ishigami S and Aikou T: CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Int J Oncol 35: 19-24, 2009.
9. Günther K, Leier J, Henning G, Dimmler A, Weissbach R, Hohenberger W and Förster R: Prediction of lymph node metastasis in colorectal carcinoma by expression of chemokine receptor CCR7. Int J Cancer 116: 726-733, 2005.
10. Liu FY, Zhao ZJ, Li P, Ding X, Zong ZH and Sun CF: Mammalian target of rapamycin (mTOR) is involved in the survival of cells mediated by chemokine receptor 7 through PI3K/Akt in metastatic squamous cell carcinoma of the head and neck. Br J Oral Maxillofac Surg 48: 291-296, 2010.
11. Li P, Zhao ZJ, Liu FY, Sun LY, Ding X, Zhang WZ, Shang DH and Sun CF: The chemokine receptor 7 regulates cell adhesion and migration via β1 integrin in metastatic squamous cell carcinoma of the head and neck. Oncol Rep 24: 989-995, 2010.
12. Constantin G, Majeed M, Giagulli C, Piccio L, Kim JY, Butcher EC and Laudanna C: Chemokines trigger immediate β2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 13: 759-769, 2000. (Pubitemid 32041799)
13. Herouy Y, Mellios P, Bandemir E, Stetter C, Dichmann S, Idzko M, Hofmann C, Vanscheidt W, Schopf E and Norgauer J: Autologous platelet-derived wound healing factor promotes angiogenesis via αvβ3-integrin expression in chronic wounds. Int J Mol Med 6: 515-519, 2000.
14. Liapis H, Flath A and Kitazawa S: Integrin αvβ3 expression by bone-residing breast cancer metastases. Diagn Mol Pathol 5: 127-135, 1996.
15. Pignatelli M, Cardillo MR, Hanby A and Stamp GW: Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarization in poorly differentiated tumors. Hum Pathol 23: 1159-1166, 1992.
16. Cooper CR, Chay CH and Pienta KJ: The role of αvβ3 in prostate cancer progression. Neoplasia 4: 191-194, 2002.
17. Carreiras F, Denoux Y, Staedel C, Lehmann M, Sichel F and Gauduchon P: Expression and localization of av integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinoma. Gynecol Oncol 62: 260-267, 1996. (Pubitemid 26274809)
18. Albelda SM, Mette SA, Elder DE, Stawart R, Damjanovich L, Herlyn M and Buck CA: Integrin distribution in malignant melanoma: association of the beta3 subunit with tumor progression. Cancer Res 50: 6757-6764, 1990. (Pubitemid 20348810)
19. Natali PG, Hamby CV, Felding-Habermann B, Liang B, Nicotra MR, Di Filippo F, Giannarelli D, Temponi M and Ferrone S: Clinical significance of αvβ3 integrin and inter-cellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res 57: 1554-1560, 1997. (Pubitemid 27175574)
20. Gingras MC, Roussel E, Bruner JM, Branch CD and Moser RP: Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissue. J Neuroimmunol 57: 143-153, 1995.
21. Engl T, Relja B, Marian D, Blumenberg C, Müller I, Beecken WD, Jones J, Ringel EM, Bereiter-Hahn J, Jonas D and Blaheta RA: CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. Neoplasia 8: 290-301, 2006.
22. Koizumi K, Kozawa Y, Ohashi Y, Nakamura ES, Aozuka Y, Sakurai H, Ichiki K, Doki Y, Misaki T and Saiki I: CCL21 promotes the migration and adhesion of highly lymph node metastatic human non-small cell lung cancer Lu-99 in vitro. Oncol Rep 17: 1511-1516, 2007.
23. Banas B, Wörnle M, Merkle M, Gonzalez-Rubio M, Schmid H, Kretzler M, Pietrzyk MC, Fink M, Perez de Lema G and Schlöndorff D: Binding of the chemokine SLC/CCL21 to its receptor CCR7 increases adhesive properties of human mesangial cells. Kidney Int 66: 2256-2263, 2004. (Pubitemid 41115288)
24. Singh S, Singh R, Sharma PK, Singh UP, Rai SN, Chung LW, Cooper CR, Novakovic KR, Grizzle WE and Lillard JW Jr: Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion. Cancer Lett 283: 29-35, 2009.
25. Jones J, Marian D, Weich E, Engl T, Wedel S, Relja B, Jonas D and Blaheta RA: CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells. Exp Cell Res 313: 4051-4065, 2007. (Pubitemid 47632540)
26. Johnson LA and Jackson DG: Inflammation-induced secretion of CCL21 in lymphatic endothelium is a key regulator of integrin-mediated dendritic cell transmigration. Int Immunol 22: 839-849, 2010.
27. Sancho M, Vieira JM, Casalou C, Mesquita M, Pereira T, Cavaco BM, Dias S and Leite V: Expression and function of the chemokine receptor CCR7 in thyroid carcinomas. J Endocrinol 191: 229-238, 2006. (Pubitemid 44756525)
28. Wang J, Zhang X, Thomas SM, Grandis JR, Wells A, Wells A, Chen ZG and Ferris RL: Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR. Oncogene 24: 5897-5904, 2005. (Pubitemid 43080081)
29. Freitas VM, Rangel M, Bisson LF, Jaeger RG and Machado-Santelli GM: The geodiamolide H, derived from Brazilian sponge Geodia corticostylifera, regulates actin cytoskeleton, migration and invasion of breast cancer cells cultured in three-dimensional environment. J Cell Physiol 216: 583-594, 2008.
30. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991. (Pubitemid 121001258)
31. Giancotti FG and Ruoslahti E: Integrin signaling. Science 285: 1028-1032, 1999.
32. Liu Y, Zhao F, Gu W, Yang H, Meng Q, Zhang Y, Yang H and Duan Q: The roles of platelet GPIIb/IIIa and alphavbeta3 integrins during HeLa cells adhesion, migration, and invasion to monolayer endothelium under static and dynamic shear flow. J Biomed Biotechnol 2009: 829243, 2009.
33. Moschos SJ, Drogowski LM, Reppert SL and Kirkwood JM: Integrins and cancer. Oncology 21: 13-20, 2007.
34. Scotton CJ, Wilson JL, Milliken D, Stamp G and Balkwill FR: Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 61: 4961-4965, 2001.
35. Aidoudi S, Bujakowska K, Kieffer N and Bikfalvi A: The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis. PLoS One 3: e2657, 2008.
36. Nicolson GL: Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 7: 143-188, 1988.
37. Van Haastert PJ and Devreotes PN: Chemotaxis: signalling the way forward. Nat Rev Mol Cell Biol 5: 626-634, 2004. (Pubitemid 39025063)